Powl Brian T. - 13 Nov 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role: Chief Commercial Officer
Signature: Teresa Bair, Attorney-in-fact for Brian Powl
Issuer symbol: KURA
Transactions as of: 13 Nov 2025
Net transactions value: -$99,329
Form type: 4
Filing time: 14 Nov 2025, 20:00:08 UTC
Previous filing: 29 Sep 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Powl Brian T.	Chief Commercial Officer	C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO	Teresa Bair, Attorney-in-fact for Brian Powl	14 Nov 2025	0001934232

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KURA	Common Stock	Award	$0	+48,900	+49%	$0.000000	148,576	13 Nov 2025	Direct	F1
transaction	KURA	Common Stock	Sale	$99,329	-8,887	-6%	$11.18	139,689	14 Nov 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of Restricted Stock Units (RSUs). The RSUs vest 50% immediately and 50% on 11/13/26.
F2	Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 11/13/25.